![](/img/cover-not-exists.png)
CO31 EFFICACY AND SAFETY OF INFLIXIMAB (IFX) THERAPY. A SINGLE CENTRE EXPERIENCE OF PAEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD). ARE THERE PREDICTIVE FACTORS FOR RESPONSE?
M. Gasparetto, F. Vallortigara, L. Visonà Dalla Pozza, C. Mescoli, M. Cananzi, M. Pescarin, P. Betalli, G. GuarisoVolume:
43
Year:
2011
Language:
english
DOI:
10.1016/s1590-8658(11)60639-7
File:
PDF, 56 KB
english, 2011